EPL Ltd

The transcript does not explicitly mention any current or planned new fundraising through debt or equity. However, some relevant points include: - EPL Limited is making modest capex investments, such as in the Thailand plant and Brazil capacity expansion. - The Thailand plant is set up with a creative model resulting in limited capex. - Expansion and capacity additions are planned to be modular and based on demand. - No specific comments on raising new funds via debt or equity in the near term. - The company emphasizes double-digit revenue growth and efficient cost management, implying organic funding of growth. - Anand Kripalu mentioned continuing investments but did not indicate any capital raise activities. Overall, no direct indication of fundraising plans through debt or equity in the provided discussion.

- Thailand plant: Recently commissioned, built in just 9 months, currently operating with low overhead and limited indirect manning costs; plans for quick expansion with a modular setup to a second production line based on order pipeline. - Brazil plant: Already undergone one phase of expansion with production started from new line 3-4 months ago; no immediate new capex planned but proactive future investment based on volume growth expected. - Focus on capital efficiency and margin expansion initiatives continuing to improve ROCE, targeting 25%+ by FY '29. - No specific country-wise capex numbers disclosed due to complexity; overall capacity utilization between 60%-70%, with modular capacity additions to maintain optimal utilization. - Continuous investment in ramping up sales capability, especially in Beauty & Cosmetics, considered “good cost” that drives higher revenue and margins. - Strategic sourcing and partnerships being explored to mitigate US tariff impacts.

- EPL Limited aims for sustained double-digit revenue growth, as indicated over multiple quarters. - Strong momentum in Beauty & Cosmetics is a key driver, with substantial headroom for further expansion. - Americas region expected to continue delivering higher-than-global-average double-digit growth, supported by broad-based country contributions. - Emerging markets like Thailand, with its new plant operational from Q3, present new growth opportunities and potential capacity expansions underway. - Oral Care volumes are expected to recover, complementing the strong growth from Beauty & Cosmetics. - Investments in sales capabilities, particularly in Beauty & Cosmetics, suggest plans for expanding market reach and innovation-led growth. - Overall growth will be a blend of organic expansion, geographical diversification, and capital-efficient operations. - The company also remains optimistic about growth recovery in regions like Europe, which faced temporary challenges.

- EPL Limited expects **sustained double-digit revenue growth** driven by geographical expansion and organic growth in existing countries. - Growth in the **Beauty & Cosmetics** segment is a key engine, showing strong momentum and significant headroom for further expansion. - Thailand plant startup is seen as a new growth driver with low overhead costs and quick breakeven potential. - The company aims for **gradual improvement in EBITDA margins** and expects EBITDA to grow faster than revenue. - Margins in Europe, currently under pressure due to de-stocking by a major customer, are expected to recover to mid-teens levels. - Effective tax rate guidance remains stable at around **20-22%**. - Earnings per share (EPS) showed improvement last quarter (INR 3.26 vs. INR 2.73), reflecting operational efficiency and profitable growth. - Overall, management is optimistic about **profitable double-digit growth** in earnings and returns.

- The transcript does not explicitly mention the current or expected order book or pending orders for EPL Limited. - However, it indicates a strong business development pipeline, especially highlighted for the Thailand plant, with plans to expand capacity as orders build. - The management expresses confidence in growth opportunities, particularly in Beauty & Cosmetics and regions like Brazil and EAP, implying a robust and growing order pipeline. - No specific order book values or pending order quantities are disclosed in the provided transcript.